NCAPH2
Basic information
Region (hg38): 22:50508224-50524780
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (21 variants)
- Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 (5 variants)
- Myopia 6 (2 variants)
- Seizure;Severe global developmental delay (1 variants)
- Tip-toe gait (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NCAPH2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 41 | 45 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 22 | 20 | 150 | 140 | 337 | |
Total | 22 | 20 | 191 | 143 | 8 |
Highest pathogenic variant AF is 0.000105
Variants in NCAPH2
This is a list of pathogenic ClinVar variants found in the NCAPH2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-50516456-A-G | not specified | Uncertain significance (May 24, 2024) | ||
22-50516499-T-C | not specified | Uncertain significance (Nov 12, 2021) | ||
22-50517635-G-A | not specified | Likely benign (Oct 12, 2022) | ||
22-50517642-C-T | not specified | Uncertain significance (Dec 01, 2022) | ||
22-50517802-C-T | not specified | Uncertain significance (Dec 15, 2023) | ||
22-50517805-C-T | not specified | Uncertain significance (Sep 27, 2021) | ||
22-50517991-C-T | not specified | Uncertain significance (Feb 22, 2023) | ||
22-50518031-A-G | not specified | Uncertain significance (Aug 30, 2021) | ||
22-50518180-C-T | not specified | Uncertain significance (Mar 25, 2024) | ||
22-50518194-C-G | not specified | Uncertain significance (Sep 16, 2021) | ||
22-50518218-C-T | not specified | Uncertain significance (Jan 20, 2023) | ||
22-50518248-G-C | not specified | Uncertain significance (Aug 19, 2023) | ||
22-50518654-G-A | not specified | Likely benign (Aug 21, 2023) | ||
22-50518675-A-G | not specified | Uncertain significance (Sep 06, 2022) | ||
22-50518686-C-T | Benign (Mar 29, 2018) | |||
22-50518687-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
22-50518703-T-C | not specified | Uncertain significance (Mar 25, 2024) | ||
22-50518731-A-G | Likely benign (Aug 01, 2022) | |||
22-50519196-C-T | not specified | Uncertain significance (Oct 06, 2021) | ||
22-50519210-A-C | not specified | Uncertain significance (Dec 14, 2023) | ||
22-50519225-G-A | not specified | Uncertain significance (Feb 06, 2023) | ||
22-50519285-G-A | not specified | Likely benign (Feb 12, 2024) | ||
22-50520996-G-A | not specified | Uncertain significance (Aug 12, 2022) | ||
22-50521007-G-C | not specified | Uncertain significance (Nov 15, 2021) | ||
22-50521022-G-A | not specified | Uncertain significance (Dec 15, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NCAPH2 | protein_coding | protein_coding | ENST00000299821 | 20 | 15257 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000288 | 1.00 | 125716 | 0 | 32 | 125748 | 0.000127 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.176 | 346 | 355 | 0.974 | 0.0000214 | 3945 |
Missense in Polyphen | 101 | 124.3 | 0.81255 | 1510 | ||
Synonymous | -2.66 | 189 | 148 | 1.28 | 0.00000964 | 1159 |
Loss of Function | 3.66 | 13 | 37.1 | 0.351 | 0.00000175 | 415 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000579 | 0.0000579 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000111 | 0.000109 |
Finnish | 0.000243 | 0.000231 |
European (Non-Finnish) | 0.000181 | 0.000167 |
Middle Eastern | 0.000111 | 0.000109 |
South Asian | 0.000132 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Regulatory subunit of the condensin-2 complex, a complex that seems to provide chromosomes with an additional level of organization and rigidity and in establishing mitotic chromosome architecture. May play a role in lineage-specific role in T-cell development (By similarity). {ECO:0000250, ECO:0000269|PubMed:14532007}.;
- Pathway
- Condensation of Prophase Chromosomes;Mitotic Prophase;M Phase;Cell Cycle;Cell Cycle, Mitotic
(Consensus)
Recessive Scores
- pRec
- 0.0969
Intolerance Scores
- loftool
- 0.0236
- rvis_EVS
- -0.22
- rvis_percentile_EVS
- 37.66
Haploinsufficiency Scores
- pHI
- 0.122
- hipred
- N
- hipred_score
- 0.456
- ghis
- 0.596
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.631
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ncaph2
- Phenotype
- immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cellular phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- meiotic chromosome condensation;T cell differentiation in thymus;chromosome organization;mitotic sister chromatid separation;female meiosis chromosome separation
- Cellular component
- condensed chromosome;condensin complex;nucleus;nucleoplasm;membrane;cell junction;intercellular bridge
- Molecular function
- chromatin binding;protein binding